Citigroup’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-390
| Closed | -$2K | – | 7890 |
|
|
2020
Q4 | $2K | Hold |
390
| – | – | ﹤0.01% | 7262 |
|
|
2020
Q3 | $2K | Hold |
390
| – | – | ﹤0.01% | 7343 |
|
|
2020
Q2 | $2K | Sell |
390
-5,000
| -93% | -$31.6K | ﹤0.01% | 7441 |
|
|
2020
Q1 | $20K | Sell |
5,390
-600
| -10% | -$2.98K | ﹤0.01% | 6713 |
|
|
2019
Q4 | $37K | Buy |
5,990
+470
| +9% | +$3.46K | ﹤0.01% | 6576 |
|
|
2019
Q3 | $47K | Buy |
5,520
+270
| +5% | +$2.01K | ﹤0.01% | 6178 |
|
|
2019
Q2 | $35K | Buy |
5,250
+4,530
| +629% | +$38.8K | ﹤0.01% | 6770 |
|
|
2019
Q1 | $6K | Sell |
720
-2,650
| -79% | -$27.4K | ﹤0.01% | 7400 |
|
|
2018
Q4 | $54K | Buy |
3,370
+1,870
| +125% | +$41.1K | ﹤0.01% | 6182 |
|
|
2018
Q3 | $50K | Buy |
1,500
+620
| +70% | +$15.9K | ﹤0.01% | 6523 |
|
|
2018
Q2 | $20K | Buy |
880
+30
| +4% | +$711 | ﹤0.01% | 6928 |
|
|
2018
Q1 | $25K | Buy |
850
+600
| +240% | +$17.6K | ﹤0.01% | 6637 |
|
|
2017
Q4 | $7K | Buy |
+250
| New | +$7.76K | ﹤0.01% | 7165 |
|
Citigroup's AVEO Position: Q1 2023 in Review
Citigroup sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 775 shares — an estimated $11.6K sold.
Citigroup first reported a position in AVEO in Q2 2013 and held it in 31 quarters. The position peaked at $128K in Q3 2018. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.
- Citigroup reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
- Citigroup sold 775 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $11.6K.
- Citigroup first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and held it in 31 quarters.
- Citigroup's AVEO Pharmaceuticals, Inc. position peaked at $128K in Q3 2018.
- 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.
Based on Citigroup's 13F filing for Q1 2023, filed 11 May 2023.